Lexington, MA4 Active Studies

Substance Use Disorder Clinical Trials in Lexington, MA

Find 4 actively recruiting substance use disorder clinical trials in Lexington, MA. Connect with local research sites and explore new treatment options.

4
Active Trials
4
Sponsors
479
Enrolling

Recruiting Substance Use Disorder Studies in Lexington

About Substance Use Disorder Clinical Trials in Lexington

Substance use disorder is a condition where the use of substances leads to health issues, disability, and failure to meet responsibilities. It encompasses alcohol, opioid, stimulant, and other drug addictions. Treatment includes behavioral therapy, medication-assisted treatment, and support programs.

There are currently 4 substance use disorder clinical trials recruiting participants in Lexington, MA. These studies are seeking a combined 479 participants. Research is being sponsored by Yale University, Pop Test Oncology LLC, William Stoops and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Substance Use Disorder Clinical Trials in Lexington — FAQ

Are there substance use disorder clinical trials in Lexington?

Yes, there are 4 substance use disorder clinical trials currently recruiting in Lexington, MA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Lexington?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Lexington research site will contact you about next steps.

Are clinical trials in Lexington free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Lexington studies also compensate for your time and travel.

What substance use disorder treatments are being tested?

The 4 active trials in Lexington are testing new therapies including novel drugs, biologics, and treatment approaches for substance use disorder.

Data updated July 13, 2026 from ClinicalTrials.gov